Dobutamine Injection, Solution, Concentrate
Product Images NDC 0409-2344

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dobutamine (NDC 0409-2344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Dobutamine Hydrochloride (Dobutamine 02)

Chemical structure of dobutamine depicted as two benzene rings, one with hydroxyl groups and an amine side chain, and the other complexed with HCl, representing the hydrochloride salt form.*

FDA Label Image

Logo (Dobutamine 03)

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Label for DOBUTamine Injection, USP 250 mg/20 mL (12.5 mg/mL) in a 20 mL single-dose fliptop vial. It is an intravenous injection concentrate that must be diluted before use. Distributed by Hospira, Inc. The label includes usage instructions and storage warnings, with the Novaplus trademark visible.*

FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Label for DOBUTamine Injection, USP 250 mg/20 mL (12.5 mg/mL) concentrate for intravenous use. The label shows a 20 mL single-dose vial packaging, indicating 10 flitop vials per package. The labeler is Hospira, Inc., and the product is distributed by the same company. The label includes instructions that the drug must be diluted prior to use and displays a barcode, lot and expiration placeholders, and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.